Naseem Amin
Presidente presso BELLEROPHON THERAPEUTICS, INC.
Patrimonio netto: 16 053 $ in data 30/04/2024
Posizioni attive di Naseem Amin
Società | Posizione | Inizio | Fine |
---|---|---|---|
BELLEROPHON THERAPEUTICS, INC. | Independent Dir/Board Member | 29/06/2015 | - |
Presidente | 26/05/2021 | - | |
Direttore/Membro del Consiglio | 29/06/2015 | 26/05/2021 | |
Orphalan SA
Orphalan SA Pharmaceuticals: MajorHealth Technology GMP-Orphan SA engages in the research and development in biotechnology. It focuses on developing and designing drugs for life-threatening and rare diseases. The company was founded by Frederic Marin on July 18, 2011 and is headquartered in Paris, France. | Direttore/Membro del Consiglio | 01/01/2017 | - |
Amministratore Delegato | 01/01/2017 | - |
Storia della carriera di Naseem Amin
Precedenti posizioni note di Naseem Amin
Società | Posizione | Inizio | Fine |
---|---|---|---|
ARIX BIOSCIENCE PLC | Direttore/Membro del Consiglio | 17/12/2019 | 06/04/2020 |
Presidente | 06/04/2020 | 30/04/2021 | |
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Investitore di Private Equity | 01/01/2015 | 31/12/2019 |
SMITH & NEPHEW PLC | Direttore Tecnico/Scientifico/R&S | 29/11/2010 | 01/01/2014 |
Corporate Officer/Principal | 12/11/2010 | 29/11/2010 | |
Biogen Idec Ltd.
Biogen Idec Ltd. BiotechnologyHealth Technology Biogen Idec Ltd. develops therapies for neurodegenerative, haematologic, and autoimmune disorders. The firm develops treatment for Alzheimer’s Disease, spinal muscular atrophy, lupus, and amyotrophic lateral sclerosis (ALS), amongst others. The company was founded on 2003 and is headquartered in Maidenhead, the United Kingdom. | Corporate Officer/Principal | 01/01/2005 | 01/01/2009 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/1999 | 01/01/2005 |
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Vendite & Marketing | - | - |
Open House London Ltd.
Open House London Ltd. RestaurantsConsumer Services Open House London Ltd. was founded in 2013 and operates restaurants. The non-profit company is based in London, UK. | Presidente | - | - |
Formazione di Naseem Amin
Kellogg School of Management | Masters Business Admin |
UCL Medical School | Doctorate Degree |
Statistiche
Distribuzione geografica
Regno Unito | 7 |
Stati Uniti | 5 |
Francia | 2 |
Posizioni
Corporate Officer/Principal | 3 |
Director/Board Member | 3 |
Chairman | 3 |
Settori
Health Technology | 7 |
Consumer Services | 4 |
Finance | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
SMITH & NEPHEW PLC | Health Technology |
BELLEROPHON THERAPEUTICS, INC. | Health Technology |
ARIX BIOSCIENCE PLC | Finance |
Aziende private | 6 |
---|---|
Open House London Ltd.
Open House London Ltd. RestaurantsConsumer Services Open House London Ltd. was founded in 2013 and operates restaurants. The non-profit company is based in London, UK. | Consumer Services |
Biogen Idec Ltd.
Biogen Idec Ltd. BiotechnologyHealth Technology Biogen Idec Ltd. develops therapies for neurodegenerative, haematologic, and autoimmune disorders. The firm develops treatment for Alzheimer’s Disease, spinal muscular atrophy, lupus, and amyotrophic lateral sclerosis (ALS), amongst others. The company was founded on 2003 and is headquartered in Maidenhead, the United Kingdom. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Finance |
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Health Technology |
Orphalan SA
Orphalan SA Pharmaceuticals: MajorHealth Technology GMP-Orphan SA engages in the research and development in biotechnology. It focuses on developing and designing drugs for life-threatening and rare diseases. The company was founded by Frederic Marin on July 18, 2011 and is headquartered in Paris, France. | Health Technology |
- Borsa valori
- Insiders
- Naseem Amin
- Esperienza